U.S. federal agencies award $40.7M flu contract to Crucell

08/18/2009 | Reuters

The NIH and the National Institute of Allergy and Infectious Diseases awarded a contract worth $40.7 million to Crucell to develop monoclonal antibodies for influenza as pandemic alert level reaches level six, said Jaap Goudsmit, the company's chief scientific officer. The Dutch biotech firm says the deal could reach up to $69.1 million if the NIH issues additional financing.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX